Japanese Pathologists and Cardiologists Express Concern about the mRNA Vaxxes By Brian Simpson
Japanese pathologists and cardiologists from the prestigious Nagano Red Cross Hospital, Shinshu University School of Medicine, Joetsu General Hospital, and the National Institute of Infectious Diseases of Japan, have reported in the peer-reviewed international journal, Pathology International, about the clinical case study of the death of a 61-year-old woman, otherwise healthy, after receiving the mRNA vaccine against SARS-CoV-2. The death was by myocarditis, usually a fate reserved for the vaccinated young. The article raised concern, given the acknowledgment of the novelty of the mRNA vaccine— “the first applied nucleic acid vaccine for humans,” with an “unclear” mechanism of efficacy and immune acquisition. Japan has been much more scientific in their approach to Covid than the blind faith, if not dog-like obedience, that the West has placed in Big Pharma.
“A group of pathologists and cardiologists affiliated with Nagano Red Cross Hospital, Shinshu University School of Medicine, Joetsu General Hospital, and the National Institute of Infectious Diseases of Japan recently reported in peer-reviewed journal Pathology International about the death of a 61-year-old woman with no material medical history after administration of COVID-19 mRNA-based vaccine. The report’s language raises concern, given the acknowledgment of the novelty of the mRNA vaccine— “the first applied nucleic acid vaccine for humans,” with an “unclear” mechanism of efficacy and immune acquisition.
The subject in this case report, a 61-year-old Japanese woman with no significant medical history, received the mRNA vaccine against SARs-CoV-2, the virus behind COVID-19. She was tested negative for COVID-19 via negative real-time polymerase chain reaction (PCR) test.
Initially developing a fever three days after the administration of the pandemic countermeasure, she went into shock the ensuing day according to the investigators. She died 10 days after the vaccination.
What did the autopsy reveal?
A form of myocarditis, a known risk with the mRNA vaccines yet generally associated with younger people. The authors report:
“The myocarditis showed severe inflammatory cell infiltration with T-lymphocyte and macrophage predominance, and in addition to the inflammatory cells described above, vast nuclear dust accompanying neutrophilic infiltration was observed. In the bone marrow and lymph nodes, hemophagocytosis was observed. In postmortem examination, nucleic acids of any cardiotropic viruses including SARS-CoV-2 were not detected using real-time PCR system.”
Is the death due to the vaccine?
The authors suspect so, but they do not declare 100% that this is the case. But it’s likely.
What’s the author’s concern?
The “first applied nucleic acid vaccine for humans,” the authors share concern that the mRNA COVID-19 vaccines’ “mechanism of efficacy and immune acquisition remain unclear.”
Lead Research/Investigator
- Hidetoshi Satomi, Department of Pathology, Nagano Red Cross Hospital, Nagano, Japan; Department of Pathology, Shinshu University School of Medicine, Matsumoto, Japan
- Harutaka Katano, Department of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.”
https://pubmed.ncbi.nlm.nih.gov/36040128/
“Abstract
A 61-year-old woman without significant medical history developed fever 3 days after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and went into shock the next day. She was negative for SARS-CoV-2 mRNA in real-time polymerase chain reaction (PCR). Finally, she died 10 days after vaccination. At autopsy, the heart showed moderate dilatation of both ventricles, and the myocardium showed an uneven color change and decreased elasticity. Histologically, severe myocarditis with extensive myocytolysis was observed. The myocarditis showed severe inflammatory cell infiltration with T-lymphocyte and macrophage predominance, and in addition to the inflammatory cells described above, vast nuclear dust accompanying neutrophilic infiltration was observed. In the bone marrow and lymph nodes, hemophagocytosis was observed. In postmortem examination, nucleic acids of any cardiotropic viruses including SARS-CoV-2 were not detected using multivirus real-time PCR system. We discussed the relationship between the possible immune reaction after vaccination and the myocarditis observed in this case from immunopathological viewpoints. This mRNA vaccine is the first applied nucleic acid vaccine for humans, and its mechanism of efficacy and immune acquisition remain unclear. We hope the accumulation of more detailed analyses of the similar cases to reveal the mechanism of this kind of adverse reaction.”
Comments